Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 1;8(3):247-256.
doi: 10.2174/157340012800792957.

Neurobiological Underpinnings of the Estrogen - Mood Relationship

Whitney Wharton  1 , Carey E Gleason, Sandra R M S Olson, Cynthia M Carlsson, Sanjay Asthana
Affiliations

Neurobiological Underpinnings of the Estrogen - Mood Relationship

Whitney Wharton et al. Curr Psychiatry Rev. .

Abstract

Women are at a higher risk than men to develop mood disorders and depression. The increased risk is associated with fluctuating estrogen levels that occur during reproductive cycle events, particularly during the menopausal transition, a time characterized by drastic fluctuations in estrogen levels and increases in new onset and recurrent depression. Conversely, recent data show that hormone therapy, particularly transdermal estradiol formulations, may prevent mood disorders or even serve as a treatment regimen for women with diagnosed mood disturbances via estrogen regulation. While the exact mechanism is unknown, there is compelling scientific evidence indicating the neuromodulatory and neuroprotective effects of estrogen, which are directly relevant to mood symptomotology. Specifically, affective regulation has been linked to neural structures rich in estrogen receptors and estrogenic regulation of neurotransmitters. While a wealth of basic science, observational and clinical research support this rationale, potential mediating variables, such as estrogen formulation, proximity of administration to menopause, and the addition of progestins should be considered. Furthermore, the nature of postmenopausal exogenous hormone formulations in relation to premenopausal endogenous levels, as well as the ratio of estrone to estradiol warrant consideration.

Keywords: Affect; Cognition; Estrogen Therapy; Hormone Therapy; Mood; Women’s Health Initiative.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endogenous Estrogen Levels
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Romanoski AJ, Folstein MF, Nestadt G, Chahal R, Merchant A, Brown CH, et al. The epidemiology of psychiatrist-ascertained depression and DSM-III depressive disorders. Results from the Eastern Baltimore Mental Health Survey Clinical Reappraisal. Psychological medicine. 1992 Aug;22(3):629–655. - PubMed
    1. Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, de Beurs E, et al. The natural history of late-life depression: a 6-year prospective study in the community. Archives of general psychiatry. 2002 Jul;59(7):605–611. - PubMed
    1. Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. The American journal of psychiatry. 1996 Nov;153(11):1411–1417. - PubMed
    1. Judd LL, Akiskal HS. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. Pharmacopsychiatry. 2000 Jan;33(1):3–7. - PubMed
    1. Rapaport MH, Judd LL. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord. 1998 Mar;48(2–3):227–232. - PubMed

LinkOut - more resources